Head-to-head · Value Score
CoreAge Rx vs Boston Medical Group
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Boston Medical Group a 65. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameBoston Medical Group
#317 · Grade C · Watch List
Est. first month
From $199/mo (starting strength, rising with dose, compounded)
Save ~85% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 65 — an est. $99/mo first month, with no teaser step-up baked in. Boston Medical Group isn't out of it: Someone in one of the seven states it serves who wants an established medical group rather than a telehealth startup.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Boston Medical Group |
|---|---|---|
| Value Score | 93 (A+) | 65 (C) |
| Est. first month | $99/mo | From $199/mo (starting strength, rising with dose, compounded) |
| Save vs brand-name | ~89% | ~85% |
| Semaglutide | $99/mo | From $199/mo (starting strength, rising with dose, compounded) |
| Tirzepatide | $149/mo | Not disclosed |
| Both molecules | Yes | No |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | 7 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Boston Medical Group
Established medical group offering a 3-month semaglutide weight loss program.
Why it's a deal
- An established medical group rather than a telehealth startup, with clinical oversight in the seven states it serves
- Compounded semaglutide delivered as a structured 12-week program rather than an open-ended subscription
The fine print
- The published rate is a range by dose strength, $199 to $299, so the figure quoted is the floor rather than what a titrated patient pays
- The 12-week program totals $699 including a telemedicine platform fee that is never itemised — about $233/mo all-in, not $199
- The weight-loss landing page carries no price at all; the numbers are two pages deeper, in the FAQ and the costs page
- Semaglutide and tirzepatide are not priced separately — one range covers the whole program
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Boston Medical Group.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.